Boxer fails test for drug common in racehorses

Ligandrol is an experimental drug still subject to clinical trials by its American manufacturer and has not yet been approved for human use.

Published: 03rd December 2019 03:32 AM  |   Last Updated: 03rd December 2019 10:29 AM   |  A+A-

By Express News Service

CHENNAI: In an embarrassment for the Indian boxing fraternity, it emerged on Monday that a participant in the recent women’s world championships has failed a dope test. A statement from the National Anti-Doping Agency revealed Neeraj Phogat has tested positive for ‘ligandrol & other anabolic steroids’. It’s a drug used illegally to enhance performance of racehorses.

Ligandrol is an experimental drug still subject to clinical trials by its American manufacturer and has not yet been approved for human use. As of now, ligandrol — a Selective Androgen Receptor Modulators (SARM) used for muscle building — is only available on the black market. Though there have been cases of athletes testing positive for it from as far back as 2015, it came to prominence when Australian swimmer Shayna Jack tested positive for it earlier this year.  

Stay up to date on all the latest Sport news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp